DLA Piper combines transactional expertise with broad regulatory insight, advising on IPOs, secondary offerings, dual listings and take-private transactions, with strong US securities law support from London. Martin Penn leads the team from London, while Robert Newman often leads deals from Birmingham. Russell Holden leverages over 25 years of experience to advise on complex cross-border deals. Alex Tamlyn and Charles Severs provide further transactional capabilities and are active across a variety of sectors.
Legal 500 Editorial commentary
Key clients
- Dechra Pharmaceuticals plc
- Aptitude Software Group plc
Work highlights
Advised PureTech Health, a leading clinical-stage biotherapeutics company, on the completion of a Tender Offer, that saw the company purchase $100 million in value of its Ordinary Shares.
Practice head
Martin Penn; Robert Newman
Other key lawyers
Russell Holden; Alex Tamlyn; Charles Severs; Karin Kirschner